Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

Hypoparathyroidism

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Hypoparathyroidism

16 trials tracked for Hypoparathyroidism: 10 in phase 3 or 4 and 5 with published results. The most-cited published study has 77 citations.

16Trials tracked

10Phase 3 & 4

0Recruiting

5With published results

Phase distribution

Phase 4 3 Phase 3 7 Phase 2 3 Phase 1 2 Other / NA 1

Phase 4 A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism Completed · 77 cited
Phase 3 A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE) Completed · 66 cited
Phase 3 A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism Completed · 33 cited
Phase 3 HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism Completed · 7 cited
Phase 4 A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE) Completed · 4 cited
Phase 4 Does Treatment of Hypovitaminosis D Increase Calcium Absorption? Completed

Show 10 more trials

Phase 3 Use of NPSP558 in the Treatment of Hypoparathyroidism Completed
Phase 3 Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY) Completed
Phase 3 Bone Properties in Hypoparathyroidism: Effects of PTH Completed
Phase 3 A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary Completed
Phase 2 A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism Completed
Phase 2 Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism Completed
Phase 2 Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 Completed
Phase 1 Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism Completed
Phase 1 Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects Completed
N/A Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy Completed

Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.